DOCSLIB.ORG

Final Medical Cannabis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Final Medical Cannabis Medical Cannabis … Clinical and Legal Considerations Christine Roussel, PharmD, BCOP Director of Pharmacy, Doylestown Hospital Disclosures • No financial Disclosures Relevant to the Cannabis Industry • Program Director, Medical Cannabis Education Course, Philadelphia College of Pharmacy, University of the Sciences Outline • Endocannabinoid System • Cannabis Pharmacology and Formulations • Clinical Considerations and Adverse Effects • Legal Considerations Photo by C.Roussel Pharmacist Objectives 1. Describe key features of the endocannabinoid system, pharmacology, and non-cannabinoid components of cannabis. 2. Outline dosage forms, pharmacokinetics, potential adverse effects and adverse effects including use disorder. 3. Discuss medical cannabis risk versus benefits and patient counseling opportunities. 4. Review federal cannabis law and possible conflicts between state and federal law. Pharmacy Technician Objectives 1. Describe main components of cannabis and their pharmacology. 2. List dosage forms available and how they work differently. 3. Describe adverse effects associated with medical cannabis and identify resources for more information. 4. Review federal regulations and their conflict with state medical and recreational marijuana laws. Disclaimer • Cannabis is currently not FDA approved for any condition. • Cannabis is currently DEA Schedule 1 (Federal) under the Controlled Substance Act of 1970. • No currently acceptable medical use • High Potential for abuse • Investigational use only – IND applications must receive triple agency approvals: National Institute of Drug Abuse (NIDA) / DEA / FDA – Product for Federal Research is Sole Source through NIDA (Unless Import permission is granted) Cannabinoids as antioxidants and neuroprotectants US Government Owns Patent “Cannabinoids are found to have particular application as neuroprotectants, for eXample limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson’s disease and HIV dimension” https://patents.google.com/patent/US6630507B1/en - Worth Reading!!!! 7 U.S. Government Grows Cannabis and Supplies it to Patients 1977 – 1993 Federal Compassionate IND (n=13) Grown by University of Mississippi & NIDA Pictures by Irvin Rosenfield, author My Medicine. Used with Permission. 8 Nerve Communication https://www.shmoop.com/animal-systems/nervous-system.html Presynaptic 1. Neurotransmitters Neuro Signal Neuron Synthesized and Transmission stored in vesicles Across the until ready to release Synaptic Cleft 2. Neurotransmitter Binding to • Glutamate Corresponding • GABA Receptor • Acetylcholine • Norepinephrine • Dopamine 3. Initiates • 5-HT3 Postsynaptic Downstream • Cholecystokinin Neuron Effects Image by C. Roussel Presynaptic 3. Binding at the CB1 Neurotransmitter Neuron Receptor stabilizes Signaling vesicles to decrease neurotransmitter release Endocannabinoid Signaling is Retrograde Inhibition 2. Endocannabinoids (Anandamide, 2-AG) Synthesized on 1. Too demand for much Postsynaptic immediate release activity Neuron Image by C. Roussel CB1 Receptors CB1 – Primarily in Brain • NOT significant in brainstem (RR,HR) Other Locations • Adipocytes • Endocrine and Exocrine Glands • Liver • Heart, Vascular Smooth Muscle Cells Cannabinoid Pharmacology in CNS ● Parasympathetic ● Anti-Nociceptive Human brain after injection of radio tracer ● Neuroprotection to show the regional distribution of CB1R ● Neuroplasticity Originally publication: Burns, et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. PNAS June 5, 2007 vol. 104 no. 23. Pg. 9800–9805 © [2007] All rights reserved. Reprinted with permission." Shohami E and Horowitz M (ed). Cannabinoids in Health and Disease. Themed special issue, Journal of Basic and Clinical Physiology and Pharmacology 2016; 27(3). 12 CB2 Receptors • Signally ↓ release of activators and sensitizers Immunomodulation: • Monocytes and Macrophages • B-cells and T-cells Liver, Spleen, Tonsils Central & Enteric Nervous System Endocrine and Exocrine Glands "Originally publication: Ahmad R,, et al. 2016 Whole-body bio-distribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects. Mol Imaging Biol. 2013 Aug;15(4):384-90© [2013]All rights reserved. Reprinted with permission." 13 Medical Cannabis vs Marijuana Cannabis sativa • Plant reliably grown and handled • Good Manufacturing Practices • Assayed, Labeled and Dated for cannabinoids and terpene content • Proven absence of typical contaminants: • Mold / Yeast • Pesticides • Heavy Metals Pictures from www.Steephill.com/science. All rights reserved. Reproduced with permission • Residual Solvents 14 Same Plant – With Different Cannabis Sativa Chemovars Hemp – Fiber Type Drug Type (aka Cannabis , Tall, thick stalk Marijuana ) THC + Terpenes Fiber Oil Food / Feed Cannabinoids Industrial Hemp: stalk and seeds are used for Cannabis / Marijuana: medicinal / teXtiles, paper, food, detergents, building recreational use of cannabinoids materials (eXcludes flower) THC content – 5 – 15+% THC Content < 0.3 – 1.5% DEA Controlled Substance Not Scheduled Seed to Sale Tracking Pictures by C. Roussel 16 CO2 Extraction Pictures by C. Roussel “Genetic tools weed out misconceptions of strain reliability in Cannabis sativa” No consistent genetic differentiation between the widely held perceptions of Sativa and Indica Cannabis types. Instances were found where samples within strains are not genetically similar. Schwabe A and McGlaughlin M. Genetic tools weed out misconceptions of strain reliability in 1 Cannabis sativa: Implications for a budding industry. bioRxiv preprint first posted online May. 28, 2018. NOT PEER REVIEWED 18 Cannabis: Entourage Effect THC CBD tetrahydro- cannabidiol Limonene Pinene cannabinol THC-A + CBC Myrcene Linalool THCV Tetrahydro- Tetrahydro- cannabinolic Cannabi- cannabivarin acid chromene Linalool Cannabinoids ß-Caryo- CBN Flavonoids phyllene CBG Lipids cannabigerol Cannabinol Terpenes Sterols 19 CB1 Endocannabinoids (Anandamide, 2-AG) Image by C. Roussel TETRAHYDROCANNABINOL (THC) • Partial Agonist of CB1 and CB2 • Euphoria • Analgesia (primary Pain relief molecule) • Muscle RelaXant • AnXiolytic (low dose) -> AnXiogenic (higher doses) Image by C. Roussel TETRAHYDROCANNABINOL (THC) ADVERSE EFFECTS Dizziness, Weakness Increase risk of falls Psychoactivity vs PsychotoXicity Tachycardia • Impaired cognition Vasodilation, Hypotension • Difficulty concentrating Addiction (1 in 10 chronic • Memory Impairment recreational users) Hypothermia Caution in patients with unstable mental health conditions (especially bipolar disorder and schizophrenia). Image by C. Roussel Cannabidiol (CBD) • Enhances natural endocannabinoid activity • inhibits anandamide hydrolysis • Agonist at 5-HT (anti-nausea) and TRPV1 (Pain relief) • Potent Immune Modulator = Strong Anti-Inflammatory Activity • Anti-seizure Negative Allosteric Modification • Neuroprotective • Decrease negative effects of THC (anXiety, memory impairment, psychoactivity) Image by C. Roussel Cannabidiol (CBD) ADVERSE EFFECTS Diarrhea Headache Suppress Appetite Stimulating (trouble sleeping) …. …..Somnolence Drug Interactions World Health Organization: Cannabidiol Critical Review TERPENES MYRCENE LINALOOL ß CARYOPHYLLENE PINENE Analgesic Sedative Select CB2 Agonist Anti-Inflammatory Anti-Inflammatory via AnXiolytic Analgesic Bronchodilator PGE-2 Analgesic Gastric Protective Acetylcholinesterase Anti-Convulsant Modulate GABA Anti-Inflammatory via Inhibitor (Aids memory) and Glutamate Skeletal Muscle RelaXant PGE-1 Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid 25 entourage effects. Br.J.Pharmacol. 163: 1344-1364. THC Inhalation Bioavailability is Variable due to smoking dynamics (10 – 60%) • Depth of inhalation • Duration of Breath Holding • Temp of Vaporizer Good For Titration and break through because of rapid effects Typical Onset 0 – 10 min Import to Teach: Duration 2- 4 hours • Patient Proper Technique • To wait 5 -10 minutes between inhalations during titration Huestis M. Human Cannabinoid Pharmacokinetics. Chem Biodivers. 2007 August ; 4(8): 1770–1804. MacCullum C and Russo E. Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 49 (2018) 12-19. Cannabis (THC) Oral Administration • Onset 30 – 120 min • ↑ Inter/Intra Patient Variable Absorption • Absorption ↑ w/ high fat meal • Duration 4 – 8 hours • *Up to 24 hours dose dependent • Lower Peak [THC] • ↑ [11-HydroXy-THC] – Longer T1/2 – More potent analgesic activity After Administration of 2.5 mg – More lipophilic Dronabinol Huestis M. Human Cannabinoid Pharmacokinetics. Chem Biodivers. 2007 August ; 4(8): 1770–1804. MacCullum C and Russo E. Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 49 (2018) 12-19. Oral Mucosal Products Bypasses Liver Metabolism Onset 15 – 60 mins Inhalation • higher doses that eXceed therapeutic threshold in most patients • poor ability to dose • delivers smaller doses • able to measure dose Don’t confuse Recreational and Medical. MacCullum C and Russo E. Practical considerations in medical cannabis More Appropriate for Medicinal Use administration and dosing. European Journal of Internal Medicine. 49 (2018) 12-19. Dustin Sulak, Heaer.com CBD Routes of Administration Oral CBD • bioavailability
Load more

Recommended publications
  • A Multifaceted Approach to Address Variation in Cannabis Sativa
    University of Northern Colorado Scholarship & Creative Works @ Digital UNC Dissertations Student Research 5-2019 A Multifaceted Approach to Address Variation in Cannabis Sativa Anna Louise Schwabe Follow this and additional works at: https://digscholarship.unco.edu/dissertations Recommended Citation Schwabe, Anna Louise, "A Multifaceted Approach to Address Variation in Cannabis Sativa" (2019). Dissertations. 554. https://digscholarship.unco.edu/dissertations/554 This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @ Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship & Creative Works @ Digital UNC. For more information, please contact [email protected]. © 2019 ANNA LOUISE SCHWABE ALL RIGHTS RESERVED UNIVERSITY OF NORTHERN COLORADO Greeley, Colorado The Graduate School A MULTIFACETED APPROACH TO ADDRESS VARIATION IN CANNABIS SATIVA A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Anna Louise Schwabe College of Natural and Health Sciences School of Biological Sciences Biological Education May 2019 This Dissertation by: Anna Louise Schwabe Entitled: A Multifaceted Approach to Address Variation in Cannabis sativa has been approved as meeting the requirement for the Degree of Doctor of Philosophy in College of Natural and Health Sciences in School of Biological Sciences, Program of Biological Education. Accepted by the Doctoral Committee ____________________________________________________
    [Show full text]
  • TY18:Layout 1 17/08/09 16:06 Pagina 1 TY18:Layout 1 17/08/09 16:06 Pagina 2 TY18:Layout 1 17/08/09 16:06 Pagina 3 TY18:Layout 1 17/08/09 16:06 Pagina 4
    TY18:Layout 1 17/08/09 16:06 Pagina 1 TY18:Layout 1 17/08/09 16:06 Pagina 2 TY18:Layout 1 17/08/09 16:06 Pagina 3 TY18:Layout 1 17/08/09 16:06 Pagina 4 Publisher/ Editor in Chief Marco Renda [email protected] Assistant to Editor Jef Tek [email protected] Copy Editor Aendrew Rininsland [email protected] Magazine design & layout Ivan Art [email protected] Director of Sales & Marketing Michelle Rainey [email protected] Technical Writer Ally a.k.a Pflover [email protected] Q&A Advisor Shantibaba [email protected] Text & photography Contributors Marco Renda, Ændrew Rininsland, Ivan Art, Michelle Rainey, Otto Snow, PFlover, Jef Tek, Shantibaba, Jerry B., Soma, Jay Generation, Harry Resin, Dr Dog, Chris Thompson, Jeremy Norrie, Keith Fagin, John (Shiva), Lara Lesack, Richard Owl Mirror, Suggarpaw, British Hempire, Jackie Sutton, Salvatore Messina HD., David B. Allen M.D., Hashmasta-Kut, Ale Keppel, Gregorio “Goyo” Fernandez Cover Pic `Mr Nice Critical Mass flower at 6 weeks` by Gregorio Fernandez “Goyo” for Mr. Nice Seedbank Submissions [email protected] Treating Yourself 250 The East Mall, P.O. Box 36531 Etobicoke, Ontario M9B 3Y8 Canada T: + 416 620 1951 F: +416 620 0698 Printed in Canada 4 - Treating Yourself, Issue 18- 2009 TY18:Layout 1 17/08/09 16:06 Pagina 5 Marco’s Editorial Well I have to say issue number 17 certainly caused a lot of controversy, especially surrounding the Dr Frankenbeanstien article. Both Sam The Skunkman and Ed Rosenthal contacted me regarding this. I offered them both the chance to rebut what was published, but they declined to do so.
    [Show full text]
  • The Official High Times Cannabis Cookbook: More Than 50 Irresistible Recipes That Will Get You High
    CONTENTS ACKNOWLEDGMENTS INTRODUCTION TO CANNABIS COOKERY CHAPTER 1: Active Ingredients Basic Recipes THC Oil (Cannabis-Infused Oil) Cannacoconut Oil Cannabis-Infused Mayonnaise Simple Cannabutter Long-Simmering Cannabutter Wamm Marijuana Flour Tinctures Quick Cannabis Glycerite Long-Simmering Ganja Glycerin Green Avenger Cannabis Tincture CHAPTER 2: Irie Appetizers Roasted Ganja Garlic Cannellini Dip Hookah Lounge Hummus Green Leafy Kale Salad in Brown Cannabutter Vinaigrette Obama’S Sativa Samosas Stuffed Stoned JalapeñO Poppers Sativa Shrimp Spring Rolls with Mango Sauce Ganja Guacamole Mini Kind Veggie Burritos Pico de Ganja and Nachos Kind Bud Bruschetta with Pot Pesto Stoner Celebrity Favorite: Lil’ Snoop Hot Doggy Doggs CHAPTER 3: Munchie Meals Reggae Rice and Bean Soup Cream of Sinsemilla Soup Tom Yum Ganja Stoner Celebrity Favorite: Texas Cannabis Chili Shroomin’ Broccoli Casserole Om Circle Stuffed Butternut Squash Chicken and Andouille Ganja Gumbo Time-Warp Tamales Red, Green, and Gold Rasta Pasta Potato Gnocchi with Wild Mushroom Ragu Big Easy Eggplant Alfredo Ganja Granny’s Smoked Mac ‘n’ Cheese Psychedelic Spanakopita Sour Diesel Pot Pie Cheeto Fried Chicken Bacon-Wrapped Pork Tenderloin with Mango Chipotle Glaze Pot-and-Pancetta-Stuffed Beef Tenderloin with Port Mushrooms CHAPTER 4: High Holidays Valentine’s Day, February 14: Sexy Ganja–Dipped Strawberries St. Patrick’s Day, March 17: Green Ganja Garlic Smashed Potatoes 4/20, Cannabis Day, April 20: 420 Farmers’ Market Risotto Independence Day, July 4: Sweet and Tangy Bar–B–Cannabis
    [Show full text]
  • United Beyond Cannabis
    United Beyond Cannabis June is Pride Month, a time to commemorate members of the LGBTQ+ community for their efforts and sacrifices for constantly pushing for progress in the face of adversity. At the Apothecarium, we believe that it is our duty to be an ally to members of the LGBTQ+ community. Cannabis has been an aid for members of the LGBTQ+ long before it has been medically legal. Our goal is to help all patients, regardless of their beliefs and orientations, to help them find the best solutions for their ailments. In this month’s edition of the retail magazine, we look at a historical moment in cannabis, product recommendations, frequently asked questions, and some cooking recipes. Historical Moments in Medical Cannabis Dennis Peron and The Founding of San Francisco Cannabis Buyers Club Dennis Peron was a cannabis and gay rights activist who is often He was arrested several times and once shot in the leg by a San considered the father of medical marijuana. Peron fought for the Franciso police officer. Many of the patients who went to the passage of Proposition P, which argued for San Franciso residents San Franciso Cannabis Buyers Club were AIDS patients that used to use medical cannabis without being criminalized. Gathering cannabis to help with the nausea from their AIDS treatment. The enough signatures, Proposition P was put on the citywide ballot. AIDS crisis directly impacted Peron as his partner Jonathan West It passed with an 80% approval vote. Additionally, Peron died from AIDS in 1990. co-authored Proposition 215, an act that allowed doctors to recommend cannabis to patients.
    [Show full text]
  • Dispensary Selection Information
    ______________________________________________________________________________________ State of Vermont Department of Public Safety Marijuana Registry [phone] 802-241-5115 45 State Drive [fax] 802-241-5230 Waterbury, Vermont 05671-1300 [email] [email protected] www.medicalmarijuana.vermont.gov Dispensary Selection Information IMPORTANT INFORMATION CONTAINED BELOW WHEN COMPLETING THE FORMS TO REGISTER AS A PATIENT WITH THE VERMONT MARIJUANA REGISTRY (VMR). Materials provided by each dispensary are attached to assist patient applicants designating a dispensary. Registered patients may purchase marijuana, marijuana infused products, seeds, and clones from a registered dispensary. Registered patients who designate a dispensary may purchase marijuana products and cultivate marijuana in a single secure indoor facility. Registered patients who elect to cultivate marijuana in a single secure indoor facility must provide the address and location to the VMR on his or her application. Any updates to the address and/or location of the single secure indoor facility must be submitted in writing via email or mail to the contact information below. Registered patients may only purchase marijuana, marijuana infused products, seeds, and clones from one dispensary and must designate the dispensary of his or her choice on their application. Registered patients may only change dispensaries every 30 days. After 30 days, a registered patient may change his or her designated dispensary by submitting a completed Cardholder Information Notification form and a $25 processing fee. The VMR will issue the registered patient a new registry identification card with a new registry identification number. ALL registered patients and caregivers MUST schedule appointments prior to going to their designated dispensary to obtain marijuana, this includes seed and clones.
    [Show full text]
  • Patient-Reported Use of Medical Cannabis for Pain, Anxiety, and Depression T Symptoms: Systematic Review and Meta-Analysis ∗ Jesse D
    Social Science & Medicine 233 (2019) 181–192 Contents lists available at ScienceDirect Social Science & Medicine journal homepage: www.elsevier.com/locate/socscimed Review article Patient-reported use of medical cannabis for pain, anxiety, and depression T symptoms: Systematic review and meta-analysis ∗ Jesse D. Kosiba , Stephen A. Maisto, Joseph W. Ditre Department of Psychology, Syracuse University, United States ARTICLE INFO ABSTRACT Keywords: Rationale: Certifications for medical cannabis are generally restricted to a small number of specific medical Medical cannabis conditions, yet patients frequently report symptoms of pain, anxiety, and depression as reasons for use. This is a Marijuana critical concern for researchers, healthcare providers, and policymakers, yet research in this area is currently Pain obstructed by the lack of a focused review or empirical synthesis on patient-reported reasons for medical can- Anxiety nabis use. Depression Objectives: AND METHOD: The first aim of this project was to conduct the first systematic review andmeta- meta-Analysis Systematic review analysis of empirical studies of patient-reported symptoms of pain, anxiety, and depression as reasons for Chronic pain medical cannabis use. The second aim was to conduct an empirical assessment of the methodological quality of extant research, test for publication bias, and test sex composition and quality scores of individual studies as possible sources of observed heterogeneity. Results: Meta-analytic results indicated that pain (64%), anxiety (50%), and depression/mood (34%) were common reasons for medical cannabis use. No evidence for publication bias was detected, despite heterogeneity in prevalence rates. A comprehensive assessment of study quality identified a number of specific methodological limitations of the existing research, including challenges in patient recruitment, use of restrictive sampling frames, and a lack of randomized recruitment methods and validated assessment measures.
    [Show full text]
  • Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis
    ORIGINAL CONTRIBUTION Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis Tibor M. Brunt, PhD,*Þ Marianne van Genugten, MSc,þ Kathrin Ho¨ner-Snoeken, MSc,§ Marco J. van de Velde, PhD,§ and Raymond J.M. Niesink, PhD* seems to lack any psychoactive effects. Tetrahydrocannabinol Abstract: In The Netherlands, pharmaceutical-grade cultivated can- and CBD are formed in the plant through different enzymes and nabis is distributed for medicinal purposes as commissioned by the enzymatic routes, both cannabinoids occur at the same time in Ministry of Health. Few studies have thus far described its therapeutic the plant as well as their precursors.4 efficacy or subjective (adverse) effects in patients. The aims of this study The pharmacodynamic mechanism underlying a major are to assess the therapeutic satisfaction within a group of patients using difference between both cannabinoids is the fact that they show prescribed pharmaceutical-grade cannabis and to compare the subjective a different interaction with the endocannabinoid receptor sys- effects among the available strains with special focus on their delta-9- tem in the brain; CBD binds as an antagonist to the cannabinoid tetrahydrocannabinol and cannabidiol content. In a cross-sectional and receptor CB1 but with much lower affinity than THC (in fact, in natural design, users of pharmaceutical-grade cannabis were investi- the order of 9100 times less potent binding).5,6 In addition, CBD gated with questionnaires. Medical background of the patients was also antagonizes the action of THC on the cannabinoid G protein- asked as well as experienced therapeutic effects and characteristics coupled receptor GPR55, which is believed to be responsible for of cannabis use.
    [Show full text]
  • Marijuana and the Pediatric Population Sadhana Dharmapuri, MD,A,B Kathleen Miller, MD, FAAP,C Jonathan D
    Marijuana and the Pediatric Population Sadhana Dharmapuri, MD,a,b Kathleen Miller, MD, FAAP,c Jonathan D. Klein, MD, MPHa Cannabinoids, the psychoactive compounds in marijuana, are one of the most abstract commonly used substances in the United States. In this review, we summarize the impact of marijuana on child and adolescent health and discuss the implications of marijuana use for pediatric practice. We review the changing epidemiology of cannabis use and provide an update on medical use, routes of administration, synthetic marijuana and other novel products, the effect of cannabis on the developing brain, other health and social consequences of use, and issues related to marijuana legalization. EPIDEMIOLOGY sure” (18.9%) students. Older students Cannabis is one of the most commonly had a higher prevalence of current used psychoactive substances in the marijuana use, with 13.1% of ninth- United States. grade students, 18.7% of 10th-grade students, 22.6% of 11th-grade aDepartment of Pediatrics, University of Illinois at Chicago, In recent years, the increase in potency students, and 25.7% of 12th-grade Chicago, Illinois; bDepartment of Pediatrics, Cook County of cannabis (which includes a sixfold to students reporting current use. With Health and Hospitals System, Chicago, Illinois; and sevenfold increase in cAdolescent Medicine Fellowship Program, Division of legalization, marijuana use during General Pediatrics and Adolescent Health, Department of tetrahydrocannabinol [THC] content), pregnancy has become more common, Pediatrics, University
    [Show full text]
  • Strain Collection Catalogue
    STRAIN COLLECTION catalogue WWW.FEMALESEEDS.NL Index INDOOR Blueberry Cheesecake 6 Bubblegummer 7 Lemon Kush 8 Pure AK 9 Skunk Special 10 White Widow x Big Bud 11 ICE 12 Iced Grapefruit 13 C99 14 Grapefruit 16 Sex Bud 17 OUTDOOR Easy Sativa 20 Red Purps 21 Purple Maroc 22 Maroc 23 AUTOMATIC FLOWERING STRAINS Auto AK 26 Auto Bubble 27 Auto Kush 28 Auto Speed Bud 29 Auto WW x BB 30 Auto NL 32 Auto Haze 33 Strain advices 34 Indoor These Female Seeds varieties are not only tasty but also a pleasure for your mind. Most of them are very high and energetic so you will not only get wonderful and great ideas, but also enough energy to do something and make full use of your creativity. Enjoy! Here you find our current tasty indoor selection. Blueberry BubbleGummer Cheesecake Height: 60 - 80 cm Height: 80 - 100 cm Flowering time: 8 weeks Flowering time: 7-8 weeks Seed to Harvest: 11 Seed to harvest: 10 - 11 weeks weeks Harvest: medium Harvest: high quality, high Taste/Smell: sweet and yield harvest fruity bubblegum odor and Taste/Smell: Extremely taste. strong, pungent creosote Effect: Euphoric, smooth aroma followed by an unusual and soft, perfect for getting cheesecake smell. things done during the day. Effect: Powerful stoned, whilst the body is in balance and relaxed. The BubbleGum cannabis was originally developed by growers in Indiana, USA. Our Blueberry Cheesecake From there the genetics (Cheese x Blueberry multiple moved to New England and hybrid) is selected from an extremely strong, smelly mother (you eventually Holland.
    [Show full text]
  • Weaving Charlotte's Web: an In-Depth Guide to Cannabidiol
    University of Mississippi eGrove Honors College (Sally McDonnell Barksdale Honors Theses Honors College) Spring 4-20-2020 Weaving Charlotte's Web: An In-Depth Guide to Cannabidiol Lauren Pitts Follow this and additional works at: https://egrove.olemiss.edu/hon_thesis Part of the Alternative and Complementary Medicine Commons, and the Natural Products Chemistry and Pharmacognosy Commons Recommended Citation Pitts, Lauren, "Weaving Charlotte's Web: An In-Depth Guide to Cannabidiol" (2020). Honors Theses. 1351. https://egrove.olemiss.edu/hon_thesis/1351 This Undergraduate Thesis is brought to you for free and open access by the Honors College (Sally McDonnell Barksdale Honors College) at eGrove. It has been accepted for inclusion in Honors Theses by an authorized administrator of eGrove. For more information, please contact [email protected]. Weaving Charlotte’s Web: An In-Depth Review of Cannabidiol By Lauren E. Pitts A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College Oxford May 2020 Approved by __________________________________ Advisor: Professor Erin Holmes __________________________________ Reader: Professor James Stewart __________________________________ Reader: Professor John Samonds © 2020 Lauren E. Pitts ALL RIGHTS RESERVED ii ACKNOWLEDGEMENTS This project could not have been completed without the support and encouragement from my amazing thesis advisor, Dr. Erin Holmes. The excitement, ideas, and advice that you provided throughout this process were invaluable. Thank you for your mentorship and friendship, which made our many meetings about this thesis so much fun. I would like to thank my friends who have humored my interest in this project and listened to me talk endlessly about fascinating articles and developments.
    [Show full text]
  • Marijuana Strains & Obesity
    CANNFIELD Department of Training and Information BEST CANNABIS STRAINS FOR OBESITY? HERE’S WHAT YOU NEED TO KNOW © 2020 CANNFIELD All Rights Reserved Cannabis and obesity is a topic not often discussed. Which is odd, considering that cannabis is known for causing the munchies. To get one thing clear from the start, there is no such thing as the “best marijuana strains to lose weight.” While cannabis may indeed hold potential in helping to increase metabolism and lower BMI (more on that later), there is no clinical research on the topic of using specific cannabis strains for obesity and weight loss. There is, however, research on the general topic of cannabis and its relationship to weight and obesity. In this article, we discuss relevant published studies and highlight several strains that may be of interest to those looking to use cannabis as a means to improve daily health and wellness. CANNFIELD Department of Training and Information © 2020 CANNFIELD All Rights Reserved Frightening Statistics on Obesity in the U.S. According to the Centers for Disease Control and Prevention (CDC), over 40% of U.S. adults struggle with obesity. Indeed, many agree with the notion that obesity in the U.S. is now a pandemic. Much of this relates to the standard American diet and lifestyle, but what are folks doing – and what can they do – to help curb obesity? Is cannabis a practical option? "Based on research, the use of cannabis may help with obesity and weight loss in terms of influencing mechanisms related to metabolism." Before we get into that discussion, however, let’s take a look at what obesity is.
    [Show full text]
  • Greenhead-Cannabis.Pdf
    All cannabis product is hand selected from Washington State I-502 regulated cannabis producers we believe adhere to organic, sustainable, ethical growing methods and business practices. These products have intoxicating effects and may be habit forming. Marijuana can impair concentration, coordination and judgement. Do not operate a vehicle or machinery under the influence of this drug. There may be health risks associated with consumption of this product. For use only by adults twenty-one and older. Keep out of reach of children. Washington State law prohibits us from returning or refunding cannabis merchandise. Please review your order. SLEEPYHEAD FLOWER INDICA áááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááááDAWG STAR BLUEBERRY CHEESECAKE With a distinct blueberry cheesecake aroma, this hybrid strain was bred from Blueberry and 1g 16 | 3.5g 55 (24.78%) Cheese. Flowers are known to be lime green and dark violet in color with orange hairs and a coating of crystals. CRITICAL PURPLE KUSH Critical Purple, also known as “Critical Purple Kush,” is an indica 1g 16 | 3.5g 55 | 7g 99 | 28g 385 (THC 26.08%) dominant strain created through crossing the classic Critical Mass X Purple Kush strains. The Critical Purple high is just as beautiful as its appearance, offering the user long-lasting relaxing effects that are perfect for kicking back at the end of a long day when you need to find sleep quickly. DOG WALKER A complex profile of woody and skunky aromas, Dogwalker delivers a strong cerebral calm that radiates 7g 75 (THC 28.79%) throughout the body over time. Induces deep relaxation that easily converts to sleep in high doses.
    [Show full text]